Lemaitre Vascular (LMAT) EPS (Basic) (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of EPS (Basic) data on file, last reported at $0.69 in Q1 2026.

• On a quarterly basis, EPS (Basic) rose 40.95% year-over-year to $0.69 in Q1 2026; TTM through Mar 2026 was $2.84, a 10.45% increase from a year earlier, with the FY2025 full-year figure at $2.65, up 4.71% from the prior year.
• EPS (Basic) for Q1 2026 stood at $0.69, down from $0.79 in the prior quarter.
• Over the last five years, EPS (Basic) for LMAT reached as high as $1.07 in Q4 2024 and fell as low as $0.16 in Q2 2022.
• Historically, EPS (Basic) has averaged $0.48 across 5 years, with a median of $0.44 in 2024.
• Across the five-year window, EPS (Basic) tumbled 60.24% in 2022 and jumped 180.8% in 2024, its largest moves.
• Year by year, EPS (Basic) stood at $0.2 in 2022, then soared by 89.82% to $0.38 in 2023, then soared by 180.8% to $1.07 in 2024, then slipped by 26.12% to $0.79 in 2025, then decreased by 13.0% to $0.69 in 2026.
• Per Business Quant data, the three most recent EPS (Basic) figures were $0.69 in Q1 2026, $0.79 in Q4 2025, and $0.77 in Q3 2025.